Secondary Mutations of the EGFR Gene That Confer Resistance to Mobocertinib in EGFR Exon 20 InsertionAkira Hamada, Tetsuya Mitsudomi|Journal of Thoracic Oncology|2023Cited by 16
P1.07.49 Limited Impact of Adjuvant Chemotherapy in Alk-Positive Stage II-III Adenocarcinoma: A Multicenter CReGYT-03 ALK StudyAkira Hamada, Y. Tsutani, Shinya Katsumata et al.|Journal of Thoracic Oncology|2025Cited by 0